Reviews:
Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
Metrics: PDF 2700 views | HTML 4534 views | ?
Abstract
Xiewan Chen1,2, Rongxia Liao1, Dezhi Li2 and Jianguo Sun2
1 Medical English Department, College of Basic Medicine, Third Military Medical University, Chongqing, China
2 Cancer Institute of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing, China
Correspondence to:
Jianguo Sun, email:
Keywords: induced cancer stem cells, dedifferentiation, reprogramming, plasticity, therapeutic resistance
Received: October 10, 2016 Accepted: December 13, 2016 Published: December 26, 2016
Abstract
Local and distant recurrence of malignant tumors following radio- and/or chemotherapy correlates with poor prognosis of patients. Among the reasons for cancer recurrence, preexisting cancer stem cells (CSCs) are considered the most likely cause due to their properties of self-renewal, pluripotency, plasticity and tumorigenicity. It has been demonstrated that preexisting cancer stem cells derive from normal stem cells and differentiated somatic cells that undergo transformation and dedifferentiation respectively under certain conditions. However, recent studies have revealed that cancer stem cells can also be induced from non-stem cancer cells by radiochemotherapy, constituting the subpopulation of induced cancer stem cells (iCSCs). These findings suggest that radiochemotherapy has the side effect of directly transforming non-stem cancer cells into induced cancer stem cells, possibly contributing to tumor recurrence and metastasis. Therefore, drugs targeting cancer stem cells or preventing dedifferentiation of non-stem cancer cells can be combined with radiochemotherapy to improve its antitumor efficacy. The current review is to investigate the mechanisms by which induced cancer stem cells are generated by radiochemotherapy and hence provide new strategies for cancer treatment.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14230